Summit Therapeutics Share Discussion Threads

[hugus maximus] 20/3/2017 09:38

Re: NASDAQ - in addition our AIM share price at 207p is much the same as NASDAQ close ... so no reason for an share price hike here.

[hugus maximus] 20/3/2017 09:32

Thanks Waterloo, that's what I remember reading too and I wonder if timing has been made specific as to when first dose of F6 is /was administered?

With the absorption being so vastly improved in F6, am hoping the market is aware that so long as some small "principle" is detectable in F3 trials, F6 results should then follow on with vastly enhanced improvement.

i.e. It would surely be a smart move if some "F6 first patients dosed" RNS is made explaining all this. I wonder if the first dosing of F6 has happened yet?

[waterloo01] 20/3/2017 08:53

I really would take care with the Nasdaq closing price as it was marked up on very low volume on the last trade.

Re F6 dosing I seem to remember, but happy to be corrected, that they are dosing both F3 and F6 at the same time, although F3 was started earlier and with more kids, so F3 likely to make up the majority of the initial results.

[abergele] 17/3/2017 22:19

pick up where we left off Monday with the charts..onwards and upwards then..gla lth's

[football] 17/3/2017 21:05

Summit Therapeutics PLC (ADR)
NASDAQ: SMMT - Mar 17, 4:00 PM EDT
13.21USDPrice increase1.11 (9.17%)

[hugus maximus] 17/3/2017 09:15

Does anyone have an ETA re: F6 dosing and initial results? I know we're due to hear of progress with F3 Q2/3 but I've been wondering how soon that might happen with F6?

[hugus maximus] 17/3/2017 09:13

Indeed the Marathon/PTC scenario is a total scandal .. how on earth can a company act so shamelessly?

[waterloo01] 16/3/2017 17:15

Rightly being slatted especially for calling it disease modifying, which it is not. Welcome to the new world of alternative truth.

[football] 15/3/2017 11:02

Rns


Summit Therapeutics plc Summit Therapeutics To Present At The Oppenheimer 27th Annual Healthcare Conference


Oxford, UK, 15 March 2017- Summit Therapeutics plc (NASDAQ: SMMT, AIM:
SUMM), the drug discovery and development company advancing therapies
for Duchenne muscular dystrophy and Clostridium difficile infection,
announces that Mr Glyn Edwards, Chief Executive Officer, will present at
the Oppenheimer 27(th) Annual Healthcare Conference, 22 March 2017 at
2:10pm EDT in New York City.

A live audio webcast of the presentation will be available through the
Investors section on the Company's website, www.summitplc.com. A replay
of the webcast will be available soon after the live presentation

[abergele] 14/3/2017 19:48

It's made a good effort today though H.M.
The charts showing any investor where we're heading,past all dma's
onwards and upwards.
looking at the yanks side,a few cents rise on their T trades and they have to sell by the looks of things....gla

[football] 13/3/2017 14:53

Did expect a bit of movement today after weekend posts

[hugus maximus] 11/3/2017 18:01

Great stuff... timing couldn't be better ... finger's crossed for a new golden period in american pharmaceuticals. GLA

[freemoney2] 11/3/2017 17:36

This looks like great news for a company with it's two main drug programmes heading into the approval process. Let's see if the market reacts positively on Monday. GLA

[chrisatrdg] 10/3/2017 16:51

Interesting read:

Trump’s Leading Candidate for FDA Is Scott Gottlieb, Sources Say

[freemoney1] 09/3/2017 10:10

Maybe director buys since it seems the options thresholds will be missed.
All still to play for and everything going well.... even the share price is building some strength and resistance now. GLA

[chrisatrdg] 09/3/2017 08:43

Thanks for the clarification waterloo01.

[waterloo01] 08/3/2017 23:35

I was referring to the 500k buys last week, which I think I made clear. They have only just posted the 100k ones, which I think were traded on the 6th, We don't often see 500k buys which takes it out of PI territory, hence my assumption. It's not uncommon, especially with our current profile, that leading into results, funds will take a position.

[solomon] 08/3/2017 22:21

yes, kudos Waterloo. Are you a psychic or do you have a background in Market Making?
I guess the MM's who dealt with the two 100k buys were taking a risk since they possibly don't have those shares to sell (hence the markup).

[chrisatrdg] 08/3/2017 21:52

waterloo01 was right there were two Buys of 100,000 at £2.20 each total £440k at 14.25 & 14.41 posted late.SP Thursday ?

[hugus maximus] 08/3/2017 19:37

OK ... so where were we before the little hiccup?

[bahiflyer] 07/3/2017 18:21

Its Trump the Chump tweeting that he's going to fix Pharma's pricing thats caused the temporary setback.
For a US president he really is a classless oik, and thats saying something.

[abergele] 07/3/2017 18:12

I agree with Football, so gross to knock away all that Market Cap for just a small difference, but alas as Hugus and waterloo say the nasdac exchange rates do keep us lashed after we get our own euphoria,it brings us down to normality.
Hey, we can't go up in straight lines,always best t see foot holes on a mountain side...gla.lth's

[hugus maximus] 07/3/2017 15:17

I do like the sound of your opinion Waterloo! Fingers crossed (We all know that the price twix here and a serious RNS is not important, but it's good to see confidence growing toward that!)

[waterloo01] 07/3/2017 14:21

Very low volume but lets see what happens on Nasdaq. Remember it was only last week that a 500k share buyer appeared and is partly responsible for the uptick. I don't think they have finished (no evidence though) and this is what they call a tree shake as they have a large buy order still to fullfill. All IMO